These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 24269557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J, Wanka L, Tung YC, Cárdenas-Aguayo Mdel C, LaFerla FM, Iqbal K, Grundke-Iqbal I.
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [Abstract] [Full Text] [Related]

  • 3. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, Anderson DJ, Buccafusco J, Gopalakrishnan M.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):875-86. PubMed ID: 20504913
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo.
    Bitner RS, Nikkel AL, Markosyan S, Otte S, Puttfarcken P, Gopalakrishnan M.
    Brain Res; 2009 Apr 10; 1265():65-74. PubMed ID: 19230830
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Apr 10; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

  • 11. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, Mufson EJ, Dekosky ST.
    Arch Neurol; 2009 May 10; 66(5):646-51. PubMed ID: 19433665
    [Abstract] [Full Text] [Related]

  • 12. Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.
    Vallés AS, Borroni MV, Barrantes FJ.
    CNS Drugs; 2014 Nov 10; 28(11):975-87. PubMed ID: 25248971
    [Abstract] [Full Text] [Related]

  • 13. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM.
    J Neurochem; 2007 Aug 10; 102(4):1053-63. PubMed ID: 17472708
    [Abstract] [Full Text] [Related]

  • 14. Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice.
    Kastyak-Ibrahim MZ, Di Curzio DL, Buist R, Herrera SL, Albensi BC, Del Bigio MR, Martin M.
    Magn Reson Imaging; 2013 Nov 10; 31(9):1515-21. PubMed ID: 23993791
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
    Qin X, Wang Y, Paudel HK.
    Am J Pathol; 2017 Aug 10; 187(8):1828-1847. PubMed ID: 28641077
    [Abstract] [Full Text] [Related]

  • 16. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS.
    JAMA Neurol; 2014 Apr 10; 71(4):505-8. PubMed ID: 24493463
    [Abstract] [Full Text] [Related]

  • 17. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.
    Caccamo A, Oddo S, Tran LX, LaFerla FM.
    Am J Pathol; 2007 May 10; 170(5):1669-75. PubMed ID: 17456772
    [Abstract] [Full Text] [Related]

  • 18. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R, Marutle A, Nordberg A.
    J Alzheimers Dis; 2013 May 10; 33(3):841-51. PubMed ID: 23042213
    [Abstract] [Full Text] [Related]

  • 19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 May 10; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 20. Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
    Inestrosa NC, Godoy JA, Vargas JY, Arrazola MS, Rios JA, Carvajal FJ, Serrano FG, Farias GG.
    Neuromolecular Med; 2013 Sep 10; 15(3):549-69. PubMed ID: 23842742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.